Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson unrecognized tax benefits (UTB) ending balance ($M) ($M)
Form 10-K Note 8 (Income Taxes)
Latest, FY2025
2,700
Period ended Dec 28, 2025
Change on a year earlier
+33.7%
2,020 in FY2024
History
11 years
Since FY2015
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Unrecognized tax benefits (UTB) ending balance ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 2,700 | +33.7% | Form 10-K (filed 2026-02-11) ↗ |
| FY2024 | Dec 29, 2024 | 2,020 | -18.7% | Form 10-K (filed 2026-02-11) ↗ |
| FY2023 | Dec 31, 2023 | 2,485 | -33.1% | Form 10-K (filed 2026-02-11) ↗ |
| FY2022 | Jan 1, 2023 | 3,716 | +15.8% | Form 10-K (filed 2026-02-11) ↗ |
| FY2021 | Jan 2, 2022 | 3,210 | -1.5% | Form 10-K (filed 2025-02-13) ↗ |
| FY2020 | Jan 3, 2021 | 3,260 | -15.4% | Form 10-K (filed 2024-02-16) ↗ |
| FY2019 | Dec 29, 2019 | 3,853 | +15.8% | Form 10-K (filed 2023-02-16) ↗ |
| FY2018 | Dec 30, 2018 | 3,326 | +5.6% | Form 10-K (filed 2022-02-17) ↗ |
| FY2017 | Dec 31, 2017 | 3,151 | +3.6% | Form 10-K (filed 2021-02-22) ↗ |
| FY2016 | Jan 1, 2017 | 3,041 | -1.3% | Form 10-K (filed 2019-02-20) ↗ |
| FY2015 | Jan 3, 2016 | 3,080 | – | Form 10-K (filed 2019-02-20) ↗ |
Breakdown
What makes up unrecognized tax benefits (utb) ending balance ($m)
- UTB additions for tax positions of current year ($M)87 · FY2025
- UTB additions for tax positions of prior years ($M)925 · FY2025
- UTB reductions for tax positions of prior years ($M)160 · FY2025
- UTB reductions from settlements with taxing authorities ($M)10 · FY2025
- UTB reductions from lapse of statute of limitations ($M)200 · FY2025
- Accrued interest and penalties on unrecognized tax benefits ($M)336 · FY2025
- Net interest and penalties expense/(benefit) on UTB ($M)64 · FY2025
- Cash income taxes paid ($M)6,539 · FY2025
Cite this data
StockData. (2026). Johnson & Johnson Unrecognized tax benefits (UTB) ending balance ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/utb_total
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.